研究者学術情報データベース

（最終更新日 : 2024-10-03 15:39:14）　

カシワ　ムネノブ
柏　宗伸
KASHIWA MUNENOBU

所属総合科学技術研究機構

職名准教授

職歴
1.		立命館大学総合科学技術研究機構医療経済評価・意思決定支援ユニット

現在の専門分野
医療技術評価、薬剤経済、費用対効果分析

論文
1.	2024/09/21	Comparative Cost-Effectiveness of Atezolizumab Versus Durvalumab as First-Line Combination Treatment with Chemotherapy for Patients with Extensive-Disease Small-Cell Lung Cancer in Japan │ Clinical Drug Investigation │
2.	2024/08/22	Comparative Cost-Effectiveness of Gemcitabine and Cisplatin in Combination with S-1, Durvalumab, or Pembrolizumab as First-Line Triple Treatment for Advanced Biliary Tract Cancer │ Journal of Gastrointestinal Cancer │
3.	2023/06/01	Comparative cost-effectiveness of nivolumab first-line and second-line therapy for advanced esophageal cancer in Japan. │ The European journal of health economics : HEPAC : health economics in prevention and care │
4.	2023/04/20	Model-based cost-utility analysis of gemcitabine, cisplatin, and S-1 as triple therapy for advanced biliary tract cancer │ International Journal of Clinical Pharmacy │
5.	2022	Difference in Cost-Effectiveness between First-Line and Third-Line or Later Nivolumab Therapy in Patients with HER2-Negative, Unresectable, Advanced or Recurrent Gastric or Gastro-Esophageal Junction Cancer in Japan. │ Biological & pharmaceutical bulletin │ 45 (7),895-903頁
全件表示（10件）

科学研究費助成事業
1.	2022/04/01 ～ 2025/03/31	進行胃癌に対する抗がん剤選択効率化のための医療経済評価研究 │ 若手研究

ホームページ
https://www.ritsumei.ac.jp/research/center/cheers/

外部研究者ID
ORCID ID
0000-0001-5178-611X